GlassScriptPhysician profile
Idalupe Wishon
NPI 1710178017
$2,334.48
in general payments reported to CMS, 2019-2025
18 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $985 · 2022: $918 · 2023: $277 · 2024: $40.48 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $659.48 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $406.04 | 2021-2025 | Jardiance |
| Amarin Pharma, INC. | $366.53 | 2021-2022 | |
| Glaxosmithkline, LLC. | $277.39 | 2021-2023 | Shingrix |
| Astrazeneca Pharmaceuticals LP | $138.50 | 2021-2023 | Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $108.45 | 2021-2022 | |
| Lilly USA, LLC | $101.67 | 2021-2023 | Mounjaro, Jardiance |
| Abbott Laboratories | $58.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $45.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $37.86 | 2021-2022 | |
| Abbvie INC. | $21.86 | 2022 | |
| Mylan Specialty L.P. | $19.14 | 2021 | |
| Genentech USA, INC. | $17.84 | 2021 | |
| Pfizer INC. | $16.68 | 2023 | |
| Amgen INC. | $16.52 | 2024 | Repatha |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.26 | 2021 | |
| Exact Sciences Corporation | $14.68 | 2025 | Cologuard Collection Kit |
| Phadia US INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Idalupe Wishon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.